Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Etanercept plus sulfasalazine: added value in rheumatoid arthritis?

Nature Clinical Practice Rheumatology volume 3, pages 70–71 (2007)Cite this article

boxed-textCombe B et al. (2006) Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison. Ann Rheum Dis 65: 1357–1362

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Breedveld FC et al. (2006) The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 54: 26–37

    Article  CAS  Google Scholar 

  2. Cronstein BN (2004) Therapeutic cocktails for rheumatoid arthritis: the mixmaster's guide. Arthritis Rheum 50: 2041–2043

    Article  Google Scholar 

  3. O' Dell JR et al. (2006) Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis. J Rheumatol 33: 213–218

    CAS  Google Scholar 

  4. Weinblatt ME et al. (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340: 253–259

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Murphy, Assistant Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. BAC Fisher is a is a Clinical Research Fellow and PC Taylor is a Professor and Honorary Consultant Rheumatologist at the Kennedy Institute of Rheumatology Division, Imperial College Faculty of Medicine, London, UK.,

    Benjamin AC Fisher & Peter C Taylor

Authors
  1. Benjamin AC Fisher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter C Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter C Taylor.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fisher, B., Taylor, P. Etanercept plus sulfasalazine: added value in rheumatoid arthritis?. Nat Rev Rheumatol 3, 70–71 (2007). https://doi.org/10.1038/ncprheum0399

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0399

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing